Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-12 5:26 pm Purchase | 13D | SAVARA INC SVRA | Bain Capital Life Sciences Fund II L.P. | 14,565,457 13% | 332,706 (+2.34%) | View |
| 2024-02-14 8:35 pm Sale | 13G | SAVARA INC SVRA | Venrock Healthcare Capital Partners II L.P. | 3,500,000 2.6% | -2,851,531 (-44.90%) | View |
| 2024-02-14 4:15 pm Sale | 13G | SAVARA INC SVRA | Zambon SpA | 4,680,000 3.46% | -13,540 (-0.29%) | View |
| 2024-02-13 9:38 pm Purchase | 13G | SAVARA INC SVRA | PRUDENTIAL FINANCIAL INC PRU | 9,788,303 7.23% | 9,788,303 (New Position) | View |
| 2024-02-13 9:00 pm Sale | 13G | SAVARA INC SVRA | CAXTON CORP | 353,441 0.3% | -6,543,110 (-94.88%) | View |
| 2024-02-08 1:31 pm Purchase | 13G | SAVARA INC SVRA | JENNISON ASSOCIATES LLC | 8,815,358 6.5% | 8,815,358 (New Position) | View |
| 2024-02-07 08:01 am Purchase | 13G | SAVARA INC SVRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,637,930 5.64% | 773,379 (+11.27%) | View |
| 2024-02-01 3:50 pm Purchase | 13G | SAVARA INC SVRA | Farallon Capital Partners L.P. | 14,326,911 9.99% | 2,794,289 (+24.23%) | View |
| 2024-01-31 2:08 pm Purchase | 13G | SAVARA INC SVRA | BlackRock Inc. BLK | 7,261,530 5.4% | 4,132,550 (+132.07%) | View |
| 2023-07-26 4:57 pm Purchase | 13D | SAVARA INC SVRA | Growth Equity Opportunities 17 LLC | 24,471,264 18.1% | 333,333 (+1.38%) | View |
| 2023-07-25 4:17 pm Purchase | 13G | SAVARA INC SVRA | TCG Crossover GP I LLC | 10,000,000 7.4% | 10,000,000 (New Position) | View |
| 2023-07-19 4:30 pm Purchase | 13D | SAVARA INC SVRA | Bain Capital Life Sciences Fund II L.P. | 14,232,751 13% | 2,610,153 (+22.46%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | SAVARA INC SVRA | Venrock Healthcare Capital Partners II L.P. | 6,351,531 5.6% | 164,249 (+2.65%) | View |
| 2022-02-14 3:52 pm Unchanged | 13G | SAVARA INC SVRA | CAXTON CORP | 6,896,551 6.1% | 0 (Unchanged) | View |
| 2022-02-14 2:15 pm Unchanged | 13G | SAVARA INC SVRA | EcoR1 Capital LLC | 3,040,540 5.3% | 0 (Unchanged) | View |
| 2022-02-10 11:02 am Sale | 13G | SAVARA INC SVRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 6,864,551 6.03% | -432,000 (-5.92%) | View |
| 2021-04-09 6:02 pm Purchase | 13G | SAVARA INC SVRA | BlackRock Inc. BLK | 3,128,980 2.8% | 118,950 (+3.95%) | View |
| 2021-03-25 5:10 pm Purchase | 13D | SAVARA INC SVRA | Growth Equity Opportunities 17 LLC | 24,137,931 24.2% | 24,137,931 (New Position) | View |
| 2021-03-25 4:05 pm Purchase | 13G | SAVARA INC SVRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,296,551 6.53% | 7,296,551 (New Position) | View |
| 2021-03-19 4:53 pm Purchase | 13G | SAVARA INC SVRA | CAXTON CORP | 6,896,551 6.2% | 6,896,551 (New Position) | View |